Further in concordance with our results, Toyota et al. [53] found a high number of TP53 mutations in unmethylated colorectal tumours suggesting that TP53 mutations and epigenetic alterations of other growth-suppressing genes can be two distinct mechanisms that inactivate tumour-suppressor genes in breast cancer. The gene discussed is TP53; the disease is colorectal neoplasm.